Linear-Dendritic Polymer-Platinum Complexes Forming Well-Defined Nanocapsules for Acid-Responsive Drug Delivery

2021 ◽  
Author(s):  
Kexin Liu ◽  
Jiajia Xiang ◽  
Guowei Wang ◽  
Hongxia Xu ◽  
Ying Piao ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Platinum Complexes ◽  
Dendritic Polymer

Polymers in drug delivery: immunotargeting of carrier-supported cis-platinum complexes

1995 ◽  
Vol 25 (2-3) ◽  
pp. 167-175 ◽  
Author(s):  
Bilha Schechter ◽  
Ruth Arnon ◽  
Meir Wilchek
Keyword(s):  
Drug Delivery ◽  
Platinum Complexes

Drug Delivery Systems For Anti-Cancer Active Complexes of Some Coinage Metals

2018 ◽  
Vol 25 (4) ◽  
pp. 493-505 ◽  
Author(s):  
Ming Zhang ◽  
Camille Saint-Germain ◽  
Guiling He ◽  
Raymond Wai-Yin Sun
Keyword(s):  
Drug Delivery ◽  
Metal Complexes ◽  
Drug Delivery Systems ◽  
Platinum Complexes ◽  
Delivery Systems ◽  
Development Of Resistance ◽  
Anti Cancer ◽  
Coinage Metals

Background: Although cisplatin and a number of platinum complexes have widely been used for the treatment of neoplasia, patients receiving these treatments have frequently suffered from their severe toxic side effects, the development of resistance with consequent relapse. In the recent decades, numerous complexes of coinage metals including that of gold, copper and silver have been reported to display promising in vitro and/or in vivo anti-cancer activities as well as potent activities towards cisplatin-resistant tumors. Nevertheless, the medical development of these metal complexes has been hampered by their instability in aqueous solutions and the nonspecific binding in biological systems. Methods: One of the approaches to overcome these problems is to design and develop adequate drug delivery systems (DDSs) for the transport of these complexes. By functionalization, encapsulation or formulation of the metal complexes, several types of DDSs have been reported to improve the desired pharmacological profile of the metal complexes, improving their overall stability, bioavailability, anti-cancer activity and reducing their toxicity towards normal cells. Conclusion: In this review, we summarized the recent findings for different DDSs for various anti- cancer active complexes of some coinage metals.

Dendritic polymer macromolecular carriers for drug delivery

2002 ◽  
Vol 6 (4) ◽  
pp. 466-471 ◽  
Author(s):  
Anil K Patri ◽  
István J Majoros ◽  
James R Baker
Keyword(s):  
Drug Delivery ◽  
Dendritic Polymer

Evaluation of Amphiphilic Star/Linear–Dendritic Polymer Reverse Micelles for Transdermal Drug Delivery: Directing Carrier Properties by Tailoring Core versus Peripheral Branching

2018 ◽  
Vol 19 (8) ◽  
pp. 3163-3176 ◽  
Author(s):  
Karolina A. Kosakowska ◽  
Brittany K. Casey ◽  
Samantha L. Kurtz ◽  
Louise B. Lawson ◽  
Scott M. Grayson
Keyword(s):  
Drug Delivery ◽  
Transdermal Drug Delivery ◽  
Reverse Micelles ◽  
Dendritic Polymer

Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery

2013 ◽  
Vol 19 (4) ◽  
pp. 190-197 ◽  
Author(s):  
Antonella Accardo ◽  
Gaetano Mangiapia ◽  
Luigi Paduano ◽  
Giancarlo Morelli ◽  
Diego Tesauro
Keyword(s):  
Drug Delivery ◽  
Platinum Complexes

Techniques For The Preparation of Tissue Samples Containing Injectable Polymer Microcapsules

1985 ◽  
Vol 43 ◽  
pp. 710-711
Author(s):  
G.E. Visscher ◽  
R. L. Robison ◽  
G. J. Argentieri
Keyword(s):  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Gastrocnemius Muscle ◽  
Degradation Process ◽  
Delivery Systems ◽  
Tissue Reaction ◽  
Electron Microscopic ◽  
Tissue Samples ◽  
Injectable Polymer ◽  
Microscopic Techniques

The use of various bioerodable polymers as drug delivery systems has gained considerable interest in recent years. Among some of the shapes used as delivery systems are films, rods and microcapsules. The work presented here will deal with the techniques we have utilized for the analysis of the tissue reaction to and actual biodegradation of injectable microcapsules. This work has utilized light microscopic (LM), transmission (TEM) and scanning (SEM) electron microscopic techniques. The design of our studies has utilized methodology that would; 1. best characterize the actual degradation process without artifacts introduced by fixation procedures and 2. allow for reproducible results.In our studies, the gastrocnemius muscle of the rat was chosen as the injection site. Prior to the injection of microcapsules the skin above the sites was shaved and tattooed for later recognition and recovery. 1.0 cc syringes were loaded with the desired quantity of microcapsules and the vehicle (0.5% hydroxypropylmethycellulose) drawn up. The syringes were agitated to suspend the microcapsules in the injection vehicle.

Nanotheranostic agents for neurodegenerative diseases

2020 ◽  
Vol 4 (6) ◽  
pp. 645-675
Author(s):  
Parasuraman Padmanabhan ◽  
Mathangi Palanivel ◽  
Ajay Kumar ◽  
Domokos Máthé ◽  
George K. Radda ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Neurodegenerative Diseases ◽  
Cell Types ◽  
Specific Cell ◽  
Ageing Population ◽  
Target Tissue ◽  
Therapeutic Approaches ◽  
Surface Receptors ◽  
Theranostic Agents ◽  
Preclinical Animal Models

Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's disease (PD), affect the ageing population worldwide and while severely impairing the quality of life of millions, they also cause a massive economic burden to countries with progressively ageing populations. Parallel with the search for biomarkers for early detection and prediction, the pursuit for therapeutic approaches has become growingly intensive in recent years. Various prospective therapeutic approaches have been explored with an emphasis on early prevention and protection, including, but not limited to, gene therapy, stem cell therapy, immunotherapy and radiotherapy. Many pharmacological interventions have proved to be promising novel avenues, but successful applications are often hampered by the poor delivery of the therapeutics across the blood-brain-barrier (BBB). To overcome this challenge, nanoparticle (NP)-mediated drug delivery has been considered as a promising option, as NP-based drug delivery systems can be functionalized to target specific cell surface receptors and to achieve controlled and long-term release of therapeutics to the target tissue. The usefulness of NPs for loading and delivering of drugs has been extensively studied in the context of NDDs, and their biological efficacy has been demonstrated in numerous preclinical animal models. Efforts have also been made towards the development of NPs which can be used for targeting the BBB and various cell types in the brain. The main focus of this review is to briefly discuss the advantages of functionalized NPs as promising theranostic agents for the diagnosis and therapy of NDDs. We also summarize the results of diverse studies that specifically investigated the usage of different NPs for the treatment of NDDs, with a specific emphasis on AD and PD, and the associated pathophysiological changes. Finally, we offer perspectives on the existing challenges of using NPs as theranostic agents and possible futuristic approaches to improve them.

Sign in / Sign up

Export Citation Format

Share Document